Elucidating a Key Component of Cancer Metastasis: CXCL12 (SDF-1α) Binding to CXCR4

The chemotactic signaling induced by the binding of chemokine CXCL12 (SDF-1α) to chemokine receptor CXCR4 is of significant biological importance and is a potential therapeutic axis against HIV-1. However, as CXCR4 is overexpressed in certain cancer cells, the CXCL12:CXCR4 signaling is involved in tumor metastasis, progression, angiogenesis, and survival. Motivated by the pivotal role of the CXCL12:CXCR4 axis in cancer, we employed a comprehensive set of computational tools, predominantly based on free energy calculations and molecular dynamics simulations, to obtain insights into the molecular recognition of CXCR4 by CXCL12. We report, what is to our knowledge, the first computationally derived CXCL12:CXCR4 complex structure which is in remarkable agreement with experimental findings and sheds light into the functional role of CXCL12 and CXCR4 residues which are associated with binding and signaling. Our results reveal that the CXCL12 N-terminal domain is firmly bound within the CXCR4 transmembrane domain, and the central 24–50 residue domain of CXCL12 interacts with the upper N-terminal domain of CXCR4. The stability of the CXCL12:CXCR4 complex structure is attributed to an abundance of nonpolar and polar intermolecular interactions, including salt bridges formed between positively charged CXCL12 residues and negatively charged CXCR4 residues. The success of the computational protocol can mainly be attributed to the nearly exhaustive docking conformational search, as well as the heterogeneous dielectric implicit water-membrane-water model used to simulate and select the optimum conformations. We also recently utilized this protocol to elucidate the binding of an HIV-1 gp120 V3 loop in complex with CXCR4, and a comparison between the molecular recognition of CXCR4 by CXCL12 and the HIV-1 gp120 V3 loop shows that both CXCL12 and the HIV-1 gp120 V3 loop share the same CXCR4 binding pocket, as they mostly interact with the same CXCR4 residues.

[1]  S. Rafii,et al.  The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. , 1998, Blood.

[2]  U. Hansmann.  Parallel tempering algorithm for conformational studies of biological molecules , 1997, physics/9710041.

[3]  Christoph Seibert,et al.  Structural Basis of CXCR4 Sulfotyrosine Recognition by the Chemokine SDF-1/CXCL12 , 2008, Science Signaling.

[4]  Phanourios Tamamis,et al.  Amyloid-like self-assembly of a dodecapeptide sequence from the adenovirus fiber shaft: Perspectives from molecular dynamics simulations , 2011 .

[5]  Lingling Shen,et al.  Molecular dynamics simulations on SDF-1alpha: binding with CXCR4 receptor. , 2003, Biophysical journal.

[6]  William L. Jorgensen,et al.  Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..

[7]  John D Lambris,et al.  Improvement of the anti-C3 activity of compstatin using rational and combinatorial approaches. , 2004, Biochemical Society transactions.

[8]  Ulrich H. von Andrian,et al.  Stem Cell Trafficking in Tissue Development, Growth, and Disease , 2008, Cell.

[9]  Changill Ban,et al.  Crystal structure of recombinant human stromal cell‐derived factor‐1α , 2006, Proteins.

[10]  Ed Roos,et al.  The chemokine receptor CXCR4 is required for outgrowth of colon carcinoma micrometastases. , 2003, Cancer research.

[11]  B. Sykes,et al.  Solution structure and basis for functional activity of stromal cell‐derived factor‐1; dissociation of CXCR4 activation from binding and inhibition of HIV‐1 , 1997, The EMBO journal.

[12]  B. Volkman,et al.  Monomeric structure of the cardioprotective chemokine SDF‐1/CXCL12 , 2009, Protein science : a publication of the Protein Society.

[13]  Jialin Zheng,et al.  CXCL12 Enhances Human Neural Progenitor Cell Survival Through a CXCR7‐ and CXCR4‐Mediated Endocytotic Signaling Pathway , 2012, Stem cells.

[14]  Gordon Stamp,et al.  Multiple actions of the chemokine CXCL12 on epithelial tumor cells in human ovarian cancer. , 2002, Cancer research.

[15]  Christodoulos A. Floudas,et al.  De Novo Peptide Design and Experimental Validation of Histone Methyltransferase Inhibitors , 2014, PloS one.

[16]  Christodoulos A Floudas,et al.  Molecular Dynamics in Drug Design: New Generations of Compstatin Analogs , 2012, Chemical biology & drug design.

[17]  T. Kipps,et al.  CXCR4: a key receptor in the crosstalk between tumor cells and their microenvironment. , 2006, Blood.

[18]  A. Mantovani,et al.  International Union of Basic and Clinical Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors , 2014, Pharmacological Reviews.

[19]  Phanourios Tamamis,et al.  Self-assembly of an aspartate-rich sequence from the adenovirus fiber shaft: insights from molecular dynamics simulations and experiments. , 2014, The journal of physical chemistry. B.

[20]  Dan Li,et al.  Structural basis of the interactions between CXCR4 and CXCL12/SDF-1 revealed by theoretical approaches. , 2013, Molecular bioSystems.

[21]  Christodoulos A Floudas,et al.  Integrated computational and experimental approach for lead optimization and design of compstatin variants with improved activity. , 2003, Journal of the American Chemical Society.

[22]  Robert A. Weinberg,et al.  Autocrine TGF-β and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts , 2010, Proceedings of the National Academy of Sciences.

[23]  V. Wee Yong,et al.  CXCR4 Is a Major Chemokine Receptor on Glioma Cells and Mediates Their Survival* , 2002, The Journal of Biological Chemistry.

[24]  Stuart A. Lipton,et al.  HIV-1 gp120 , 2012 .

[25]  Phanourios Tamamis,et al.  Design of a modified mouse protein with ligand binding properties of its human analog by molecular dynamics simulations: The case of C3 inhibition by compstatin , 2011, Proteins.

[26]  D VOGT.  [GROWTH AND DISEASE]. , 1965, Monatsschrift fur Kinderheilkunde.

[27]  N Tsukada,et al.  Blood-derived nurse-like cells protect chronic lymphocytic leukemia B cells from spontaneous apoptosis through stromal cell-derived factor-1. , 2000, Blood.

[28]  Phanourios Tamamis,et al.  Exploring Protein-Protein and Protein-Ligand Interactions in the Immune System using Molecular Dynamics and Continuum Electrostatics , 2012 .

[29]  Alexander D. MacKerell,et al.  Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulations , 2004, J. Comput. Chem..

[30]  Gideon Rechavi,et al.  A Possible Role for CXCR4 and Its Ligand, the CXC Chemokine Stromal Cell-Derived Factor-1, in the Development of Bone Marrow Metastases in Neuroblastoma1 , 2001, The Journal of Immunology.

[31]  Andrew L Kung,et al.  A small-molecule antagonist of CXCR4 inhibits intracranial growth of primary brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[32]  Jianpeng Ma,et al.  CHARMM: The biomolecular simulation program , 2009, J. Comput. Chem..

[33]  Hiroya Takeuchi,et al.  Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Tanja Hartmann,et al.  Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells , 2003, Oncogene.

[35]  Jian Zhang,et al.  CXCL12 / CXCR4 / CXCR7 chemokine axis and cancer progression , 2010, Cancer and Metastasis Reviews.

[36]  Ravi Salgia,et al.  Regulation of cellular proliferation, cytoskeletal function, and signal transduction through CXCR4 and c-Kit in small cell lung cancer cells. , 2002, Cancer research.

[37]  Giuseppe Sciumè,et al.  Chemokines and glioma: Invasion and more , 2010, Journal of Neuroimmunology.

[38]  Jianhua Wang,et al.  Diverse signaling pathways through the SDF-1/CXCR4 chemokine axis in prostate cancer cell lines leads to altered patterns of cytokine secretion and angiogenesis. , 2005, Cellular signalling.

[39]  Y. Sugita,et al.  Replica-exchange molecular dynamics method for protein folding , 1999 .

[40]  Massimo Cristofanilli,et al.  A CXCR4 antagonist CTCE-9908 inhibits primary tumor growth and metastasis of breast cancer. , 2009, The Journal of surgical research.

[41]  Giovanni Martinelli,et al.  CXCR4 neutralization, a novel therapeutic approach for non-Hodgkin's lymphoma. , 2002, Cancer research.

[42]  Arnon Nagler,et al.  CXCR 4 Regulates Migration and Development of Human Acute Myelogenous Leukemia Stem Cells in Transplanted NOD / SCID Mice , 2004 .

[43]  William C. Olson,et al.  Mapping the Determinants of the CCR5 Amino-Terminal Sulfopeptide Interaction with Soluble Human Immunodeficiency Virus Type 1 gp120-CD4 Complexes , 2001, Journal of Virology.

[44]  Christodoulos A Floudas,et al.  Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell cultures. , 2013, Experimental eye research.

[45]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[46]  H. K. Fung,et al.  De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation. , 2012, Journal of medicinal chemistry.

[47]  Hirokazu Tamamura,et al.  Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cells. , 2005, Blood.

[48]  Won-Tak Choi,et al.  Unique Ligand Binding Sites on CXCR4 Probed by a Chemical Biology Approach: Implications for the Design of Selective Human Immunodeficiency Virus Type 1 Inhibitors , 2005, Journal of Virology.

[49]  Zhiping Weng,et al.  Accelerating Protein Docking in ZDOCK Using an Advanced 3D Convolution Library , 2011, PloS one.

[50]  F. Balkwill.  Cancer and the chemokine network , 2004, Nature Reviews Cancer.

[51]  Peter D. Kwong,et al.  Structures of the CCR5 N Terminus and of a Tyrosine-Sulfated Antibody with HIV-1 gp120 and CD4 , 2007, Science.

[52]  C. Brooks,et al.  An implicit membrane generalized born theory for the study of structure, stability, and interactions of membrane proteins. , 2003, Biophysical journal.

[53]  Jun Du,et al.  Phenotypic Knockout of CXCR4 by a Novel Recombinant Protein TAT/54R/KDEL Inhibits Tumors Metastasis , 2009, Molecular Cancer Research.

[54]  Kedar S Vaidya,et al.  Inhibition of CXCR4 by CTCE-9908 inhibits breast cancer metastasis to lung and bone. , 2009, Oncology reports.

[55]  T. Kipps,et al.  Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. , 1999, Blood.

[56]  Phanourios Tamamis,et al.  Insights into the Structure, Correlated Motions, and Electrostatic Properties of Two HIV-1 gp120 V3 Loops , 2012, PloS one.

[57]  Mark Munsell,et al.  Engraftment of Acute Myeloid Leukemia in NOD/SCID Mice Is Independent of CXCR4 and Predicts Poor Patient Survival , 2004, Stem cells.

[58]  Arnon Nagler,et al.  CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice. , 2004, Cancer research.

[59]  John S Condeelis,et al.  Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis , 2011, Breast Cancer Research.

[60]  A. Hidalgo,et al.  Chemokine stromal cell-derived factor-1alpha modulates VLA-4 integrin-mediated multiple myeloma cell adhesion to CS-1/fibronectin and VCAM-1. , 2001, Blood.

[61]  Phanourios Tamamis,et al.  Amyloid-like self-assembly of peptide sequences from the adenovirus fiber shaft: insights from molecular dynamics simulations. , 2009, The journal of physical chemistry. B.

[62]  Ying Li,et al.  Crystal Structure and Structural Mechanism of a Novel Anti-Human Immunodeficiency Virus and d-Amino Acid-Containing Chemokine , 2007, Journal of Virology.

[63]  Irving L. Weissman,et al.  Hematopoietic Stem Cells Are Uniquely Selective in Their Migratory Response to Chemokines , 2002, The Journal of experimental medicine.

[64]  Stephen C. Peiper,et al.  Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions , 1999, Journal of Virology.

[65]  Lingling Shen,et al.  Molecular Dynamics Simulations on SDF-1α: Binding with CXCR4 Receptor , 2003 .

[66]  N. Heveker,et al.  Identification of Residues of CXCR4 Critical for Human Immunodeficiency Virus Coreceptor and Chemokine Receptor Activities* , 2000, The Journal of Biological Chemistry.

[67]  Gerardo Botti,et al.  Expression of CXCR4 Predicts Poor Prognosis in Patients with Malignant Melanoma , 2005, Clinical Cancer Research.

[68]  Geoffrey C Gurtner,et al.  Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1 , 2004, Nature Medicine.

[69]  Won-Tak Choi,et al.  Distinct Functional Sites for Human Immunodeficiency Virus Type 1 and Stromal Cell-Derived Factor 1α on CXCR4 Transmembrane Helical Domains , 2005, Journal of Virology.

[70]  Christodoulos A Floudas,et al.  Species specificity of the complement inhibitor compstatin investigated by all‐atom molecular dynamics simulations , 2010, Proteins.

[71]  Hideo Takahashi,et al.  Structural Basis of the Interaction between Chemokine Stromal Cell-derived Factor-1/CXCL12 and Its G-protein-coupled Receptor CXCR4* , 2009, The Journal of Biological Chemistry.

[72]  Wilfred F van Gunsteren,et al.  Biomolecular simulation: historical picture and future perspectives. , 2008, Biochemical Society transactions.

[73]  Bernhard Moser,et al.  The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1 , 1996, Nature.

[74]  Thomas J. Kipps,et al.  Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. , 1999 .

[75]  Elias Lolis,et al.  Structural and Functional Basis of CXCL12 (Stromal Cell-derived Factor-1α) Binding to Heparin* , 2007, Journal of Biological Chemistry.

[76]  Arieh Warshel,et al.  Absolute binding free energy calculations: On the accuracy of computational scoring of protein–ligand interactions , 2010, Proteins.

[77]  Pallavi Sachdev,et al.  Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells , 2010, Proceedings of the National Academy of Sciences.

[78]  Rameen Beroukhim,et al.  Molecular characterization of the tumor microenvironment in breast cancer. , 2004, Cancer cell.

[79]  Alnawaz Rehemtulla,et al.  CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature , 2007, Proceedings of the National Academy of Sciences.

[80]  H. K. Fung,et al.  Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework. , 2010, Biophysical journal.

[81]  R. Abagyan,et al.  Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide Antagonists , 2010, Science.

[82]  Dan R. Littman,et al.  The Role of CXCR4 in Maintaining Peripheral B Cell Compartments and Humoral Immunity , 2004, The Journal of experimental medicine.

[83]  I S Zeelenberg,et al.  Retention of CXCR4 in the endoplasmic reticulum blocks dissemination of a T cell hybridoma. , 2001, The Journal of clinical investigation.

[84]  R. Alon,et al.  Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. , 1999, Science.

[85]  A. Ben-Baruch,et al.  The chemokine system, and its CCR5 and CXCR4 receptors, as potential targets for personalized therapy in cancer. , 2014, Cancer letters.

[86]  Zhaowen Luo,et al.  Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies* , 2001, The Journal of Biological Chemistry.

[87]  J. Burger,et al.  CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells , 2005, Oncogene.

[88]  Hidekazu Takagi,et al.  Hepatic Stellate Cells Promote Liver Metastasis of Colon Cancer Cells by the Action of SDF-1/CXCR4 Axis , 2009, Annals of Surgical Oncology.

[89]  N Nandhagopal,et al.  Crystal structure of recombinant native SDF-1alpha with additional mutagenesis studies: an attempt at a more comprehensive interpretation of accumulated structure-activity relationship data. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[90]  Themis Lazaridis,et al.  Membrane protein native state discrimination by implicit membrane models , 2013, J. Comput. Chem..

[91]  Christodoulos A Floudas,et al.  Protein WISDOM: a workbench for in silico de novo design of biomolecules. , 2013, Journal of visualized experiments : JoVE.

[92]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[93]  R. Jain,et al.  CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies? , 2011, Clinical Cancer Research.

[94]  Charles L. Brooks,et al.  Generalized born model with a simple smoothing function , 2003, J. Comput. Chem..

[95]  Experimental Therapeutics,et al.  Correction to “International Union of Pharmacology. LXXXIX. Update on the Extended Family of Chemokine Receptors and Introducing a New Nomenclature for Atypical Chemokine Receptors” , 2014, Pharmacological Reviews.

[96]  Alexander D. MacKerell,et al.  All-atom empirical potential for molecular modeling and dynamics studies of proteins. , 1998, The journal of physical chemistry. B.

[97]  Urs Haberthür,et al.  FACTS: Fast analytical continuum treatment of solvation , 2008, J. Comput. Chem..

[98]  Beverly A. Teicher,et al.  CXCL12 (SDF-1)/CXCR4 Pathway in Cancer , 2010, Clinical Cancer Research.

[99]  P. Tamamis,et al.  UV resonance Raman study of TTR(105-115) structural evolution as a function of temperature. , 2011, The journal of physical chemistry. B.

[100]  P. Argos,et al.  Knowledge‐based protein secondary structure assignment , 1995, Proteins.

[101]  KF Bradstock,et al.  Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers , 2000, Leukemia.

[102]  W. Dalton,et al.  Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines , 1999 .

[103]  Gerardo Botti,et al.  Expression of CXCR 4 Predicts Poor Prognosis in Patients with Malignant Melanoma , 2005 .

[104]  Christodoulos A Floudas,et al.  Molecular recognition of CXCR4 by a dual tropic HIV-1 gp120 V3 loop. , 2013, Biophysical journal.

[105]  T. Springer,et al.  The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood , 1997, The Journal of experimental medicine.